NASDAQ: MPLT
Maplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?

Insider buying vs selling

Have Maplight Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Catalyst4 Inc10% Owner2025-10-285,441,176$17.00
$92.50MBuy
Holdings A. Novo10% Owner2025-10-28952,941$17.00
$16.20MBuy

1 of 1

MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MPLT insiders and whales buy or sell their stock.

MPLT Shareholders

What type of owners hold Maplight Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Catalyst4 Inc43.41%19,697,464$407.74MInsider
Holdings A. Novo8.13%3,686,622$76.31MInsider
Robert C. Malenka0.95%431,343$8.93MInsider
Christopher A. Kroeger0.73%330,778$6.85MInsider
Erin Pennock Foff0.11%48,275$999.29kInsider
Vishwas Setia0.10%43,367$897.70kInsider
Anatol Kreitzer0.08%35,953$744.23kInsider
James Woodruff Lillie0.07%32,539$673.56kInsider
Jonathan Gillis0.07%30,565$632.70kInsider
Kristopher Hanson0.06%27,098$560.93kInsider

1 of 2

MPLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MPLT0.00%53.72%Net BuyingNet Buying
BBOT62.58%37.42%Net Buying
ABUS29.82%70.18%Net Selling
ERAS71.43%28.57%
MRVI45.43%54.57%Net BuyingNet Buying

Maplight Therapeutics Stock Ownership FAQ

Who owns Maplight Therapeutics?

Maplight Therapeutics (NASDAQ: MPLT) is owned by 0.00% institutional shareholders, 53.72% Maplight Therapeutics insiders, and 46.28% retail investors. Catalyst4 Inc is the largest individual Maplight Therapeutics shareholder, owning 19.70M shares representing 43.41% of the company. Catalyst4 Inc's Maplight Therapeutics shares are currently valued at $415.22M.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.